Novartis AG (NVSEF)
96.00
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Novartis Price to Book Value: 4.937 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.937 |
| April 24, 2024 | 4.937 |
| April 23, 2024 | 4.937 |
| April 22, 2024 | 4.891 |
| April 19, 2024 | 4.641 |
| April 18, 2024 | 4.641 |
| April 17, 2024 | 4.816 |
| April 16, 2024 | 4.816 |
| April 15, 2024 | 4.816 |
| April 12, 2024 | 4.816 |
| April 11, 2024 | 4.816 |
| April 10, 2024 | 4.839 |
| April 09, 2024 | 4.922 |
| April 08, 2024 | 4.881 |
| April 05, 2024 | 4.881 |
| April 04, 2024 | 4.881 |
| April 03, 2024 | 4.754 |
| April 02, 2024 | 4.886 |
| April 01, 2024 | 4.963 |
| March 31, 2024 | |
| March 28, 2024 | 4.227 |
| March 27, 2024 | 4.191 |
| March 26, 2024 | 4.191 |
| March 25, 2024 | 4.191 |
| March 22, 2024 | 4.222 |
| Date | Value |
|---|---|
| March 21, 2024 | 4.222 |
| March 20, 2024 | 4.120 |
| March 19, 2024 | 4.244 |
| March 18, 2024 | 4.38 |
| March 15, 2024 | 4.38 |
| March 14, 2024 | 4.38 |
| March 13, 2024 | 4.297 |
| March 12, 2024 | 4.306 |
| March 11, 2024 | 4.325 |
| March 08, 2024 | 4.467 |
| March 07, 2024 | 4.467 |
| March 06, 2024 | 4.467 |
| March 05, 2024 | 4.467 |
| March 04, 2024 | 4.467 |
| March 01, 2024 | 4.467 |
| February 29, 2024 | 4.428 |
| February 28, 2024 | 4.599 |
| February 27, 2024 | 4.599 |
| February 26, 2024 | 4.599 |
| February 23, 2024 | 4.549 |
| February 22, 2024 | 4.506 |
| February 21, 2024 | 4.465 |
| February 20, 2024 | 4.465 |
| February 16, 2024 | 4.384 |
| February 15, 2024 | 4.358 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.110
Minimum
Sep 27 2022
5.386
Maximum
Dec 28 2023
3.178
Average
3.152
Median
Aug 03 2021
Price to Book Value Benchmarks
| Sandoz Group AG | -- |
| Roche Holding AG | 5.532 |
| Bristol-Myers Squibb Co | 3.109 |
| Eli Lilly and Co | 64.97 |
Price to Book Value Related Metrics
| PE Ratio | 13.10 |
| PS Ratio | 3.990 |
| PEG Ratio | 0.1043 |
| Price to Free Cash Flow | 19.44 |
| Price | 96.00 |
| Earnings Yield | 7.64% |
| Market Cap | 195.88B |
| PEGY Ratio | 0.1012 |
| Operating PE Ratio | 18.73 |
| Normalized PE Ratio | 21.72 |